LRA 2026 Translational Bridge Award

LRA will provide funding to bridge the gap between post-discovery and pre-commercial development and to accelerate the pace at which promising research discoveries are translated into clinical evaluation and transitioned into viable products that directly impact patients. 

Funding: $450,000 total

Duration: 1-2 years 

Research authority due date: 12.2.26